Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.
Pain Medicine July 11th 2023
NEJM Evidence
Delve into the details of this study to gain further insights into the promising role of THC and CBD treatment for severe Tourette syndrome.
Neurology June 21st 2023
MDLinx
According to surveys, up to 40% of cancer patients in the United States use cannabis, yet only one-third of doctors are comfortable advising them on it. Now, a small but significant study has found that cancer patients who use cannabis to treat their symptoms had reduced pain, better sleep, and an unexpected benefit: they appear to think more clearly after a few weeks of consistent use. The study, published in the journal Exploration in Medicine, is one of the first to look at how cannabis purchased via dispensaries, rather than government-supplied or synthetic kinds, affects cancer symptoms or chemotherapy side effects. It also sheds light on the large range of drugs used by cancer patients now that marijuana is legal in the majority of states.
Oncology, Medical May 8th 2023
Decisions in Dentistry
Health and legal problems are rising in tandem with the popularity of items derived from cannabis. To guarantee the safe delivery of dental treatment, oral health practitioners must stay current on new research and adhere to established principles. After completed this CE course, participants ought to be able to:
Dentistry April 17th 2023
Addiction Professional
The US Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) issued the 2021 National Survey on Drug Use and Health (NSDUH) this week. The NDSUH offers a window into Americans’ experiences with mental health disorders, substance use, and their pursuit of treatment during the second year of the COVID epidemic through chosen estimates by race, ethnicity, and age group. Enough said—the outcomes aren’t appealing.
Family Medicine/General Practice January 18th 2023
The American Journal of Psychiatry
The American Journal of Psychiatry presents this review of the most compelling articles that were covered in 2022: The Molecular and Cellular Alterations That Underpin Psychiatric Illnesses Shared and Distinct Neurobiological Mechanisms of PTSD Cognitive Deficits in Long-Term Cannabis Users Longitudinal Outcomes of Duration of Untreated Psychosis Accelerating TMS in the Treatment of Depression Infant Brain Development, Fragile X Syndrome, and Autism Spectrum Disorder Combining Computational Modeling and Postmortem Human Brain Studies to Uncover Synaptic Variability Contributions to Cortical Gamma Oscillation From the AJP Residents’ Journal: Identity and Stigma
Psychiatry January 10th 2023